TBPH - テラバンス・バイオファ―マ (Theravance Biopharma Inc.)

TBPHのニュース

   Theravance Biopharma To Present at the 39th Annual J.P. Morgan Healthcare Conference  2021/01/05 11:00:00 PR Newswire
DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines, will webcast its presentation at the 39th Annual J.P. Morgan…
   Insider Selling: Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Sells 7,500 Shares of Stock  2020/12/19 11:12:46 Watchlist News
Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Richard A. Graham sold 7,500 shares of the business’s stock in a transaction on Monday, December 14th. The shares were sold at an average price of $19.47, for a total transaction of $146,025.00. Following the transaction, the senior vice president now owns 123,749 shares in the company, valued at $2,409,393.03. […]
   Theravance Biopharma to Present at the 3rd Annual Evercore ISI HEALTHCONx Conference  2020/11/17 11:00:00 PR Newswire
DUBLIN, Nov. 17, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will webcast a presentation as follows: Evercore ISI 3rd Annual…
   Theravance Biopharma, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update  2020/11/05 21:05:00 PR Newswire
DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the third quarter ending September 30, 2020. Theravance Biopharma's Total Revenue for the third quarter 2020 was $18.3 million….
   Theravance Biopharma (NASDAQ:TBPH) Stock Price Up 5.3%  2020/10/24 11:50:53 The Olympia Report
Theravance Biopharma Inc (NASDAQ:TBPH) traded up 5.3% during mid-day trading on Thursday . The company traded as high as $19.13 and last traded at $19.03. 258,232 shares were traded during mid-day trading, a decline of 38% from the average session volume of 414,870 shares. The stock had previously closed at $18.07. A number of research […]
   Theravance Biopharma To Present at the 39th Annual J.P. Morgan Healthcare Conference  2021/01/05 11:00:00 PR Newswire
DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines, will webcast its presentation at the 39th Annual J.P. Morgan…
   Insider Selling: Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Sells 7,500 Shares of Stock  2020/12/19 11:12:46 Watchlist News
Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Richard A. Graham sold 7,500 shares of the business’s stock in a transaction on Monday, December 14th. The shares were sold at an average price of $19.47, for a total transaction of $146,025.00. Following the transaction, the senior vice president now owns 123,749 shares in the company, valued at $2,409,393.03. […]
   Theravance Biopharma to Present at the 3rd Annual Evercore ISI HEALTHCONx Conference  2020/11/17 11:00:00 PR Newswire
DUBLIN, Nov. 17, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will webcast a presentation as follows: Evercore ISI 3rd Annual…
   Theravance Biopharma, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update  2020/11/05 21:05:00 PR Newswire
DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the third quarter ending September 30, 2020. Theravance Biopharma's Total Revenue for the third quarter 2020 was $18.3 million….
   Theravance Biopharma (NASDAQ:TBPH) Stock Price Up 5.3%  2020/10/24 11:50:53 The Olympia Report
Theravance Biopharma Inc (NASDAQ:TBPH) traded up 5.3% during mid-day trading on Thursday . The company traded as high as $19.13 and last traded at $19.03. 258,232 shares were traded during mid-day trading, a decline of 38% from the average session volume of 414,870 shares. The stock had previously closed at $18.07. A number of research […]
   Insider Selling: Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Sells 7,500 Shares of Stock  2020/12/19 11:12:46 Watchlist News
Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Richard A. Graham sold 7,500 shares of the business’s stock in a transaction on Monday, December 14th. The shares were sold at an average price of $19.47, for a total transaction of $146,025.00. Following the transaction, the senior vice president now owns 123,749 shares in the company, valued at $2,409,393.03. […]
   Theravance Biopharma to Present at the 3rd Annual Evercore ISI HEALTHCONx Conference  2020/11/17 11:00:00 PR Newswire
DUBLIN, Nov. 17, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will webcast a presentation as follows: Evercore ISI 3rd Annual…
   Theravance Biopharma, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update  2020/11/05 21:05:00 PR Newswire
DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the third quarter ending September 30, 2020. Theravance Biopharma's Total Revenue for the third quarter 2020 was $18.3 million….
   Theravance Biopharma (NASDAQ:TBPH) Stock Price Up 5.3%  2020/10/24 11:50:53 The Olympia Report
Theravance Biopharma Inc (NASDAQ:TBPH) traded up 5.3% during mid-day trading on Thursday . The company traded as high as $19.13 and last traded at $19.03. 258,232 shares were traded during mid-day trading, a decline of 38% from the average session volume of 414,870 shares. The stock had previously closed at $18.07. A number of research […]
   Theravance Biopharma (NASDAQ:TBPH) Rating Increased to Hold at BidaskClub  2020/10/23 04:08:51 Stock Observer
Theravance Biopharma (NASDAQ:TBPH) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday, BidAskClub reports. A number of other equities analysts also recently weighed in on the stock. ValuEngine raised shares of Theravance Biopharma from a “hold” rating to a “buy” rating in a research […]

calendar